Flovent and Phytonadione drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flovent (fluticasone propionate) and Phytonadione (phytonadione). Common drug interactions include platelet count decreased among females and infective pulmonary exacerbation of cystic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Flovent and Phytonadione. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Flovent?

Flovent has active ingredients of fluticasone propionate. It is often used in asthma. eHealthMe is studying from 44,817 Flovent users. Check the latest studies of Flovent.

What is Phytonadione?

Phytonadione has active ingredients of phytonadione. It is often used in hemorrhagic stroke. eHealthMe is studying from 2,870 Phytonadione users. Check the latest studies of Phytonadione.

On Jul, 17, 2026

59 people who take Flovent and Phytonadione together, and have interactions are studied.

Flovent and Phytonadione drug interactions.

What are the common drug interactions of Flovent and Phytonadione, by gender? *:

female:

Platelet count decreased
Post procedural haemorrhage (post procedural bleeding)
Pulmonary function test decreased
Renal failure (kidney dysfunction)
Sinusitis (inflammation of sinus)
Splenomegaly (enlargement of spleen)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Vitamin k deficiency
Weight decreased
Acute hepatic failure

male:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Blood pressure decreased
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Clubbing (deformity of the fingers and fingernails)
Cough
Cystic fibrosis related diabetes
Decreased appetite
Diarrhoea
Distal intestinal obstruction syndrome (blockage of the intestines by thickened stool and occurs in individuals with cystic fibrosis)
Dizziness

What are the common drug interactions of Flovent and Phytonadione, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Biliary dilatation
Biliary tract disorder
Bilirubin conjugated increased
Blood alkaline phosphatase increased
Blood bilirubin increased
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Cholangitis (infection of the bile duct)
Chronic hepatic failure (long lasting liver failure)
Constipation
Deficiency of bile secretion

10-19:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Cystic fibrosis (disease of the secretary glands)
Lung disorder (lung disease)
Pneumonia
Sinusitis (inflammation of sinus)
Aspartate aminotransferase increased
Dyspnoea (difficult or laboured respiration)
Hospitalisation
Infection
Pulmonary function test decreased

20-29:

Abdominal pain
Blood pressure decreased
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Chest discomfort
Chest pain
Chills (felling of cold)
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Clubbing (deformity of the fingers and fingernails)
Cough
Cystic fibrosis (disease of the secretary glands)

30-39:

n/a

40-49:

n/a

50-59:

Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Dry skin
Erythema (redness of the skin)
Face oedema (swelling of face)
Pruritus (severe itching of the skin)

60+:

Left ventricular dysfunction
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Respiratory distress (difficulty in breathing)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Blood pressure decreased
Chest pain
Thrombocytopenia (decrease of platelets in blood)

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 40 people, 67.80%
Pain: 8 people, 13.56%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 6 people, 10.17%
Multiple Myeloma (cancer of the plasma cells): 6 people, 10.17%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 5 people, 8.47%
Seasonal Allergy (allergic condition due to certain season): 4 people, 6.78%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 4 people, 6.78%
Diabetes: 4 people, 6.78%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 4 people, 6.78%

* Approximation only. Some reports may have incomplete information.

Do you take Flovent and Phytonadione?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously